Key Metrics
1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.91
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
39%
4 to 6 months
45%
7 to 9 months
13%
Above 9 months
4%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Apoptosis protein
- Lung cancer
- Capmatinib
- Immunotherapy
- Erlotinib
- Receptor tyrosine kinase inhibitor
- Genome evolution
- Metastatic Lung Adenocarcinoma
- Osimertinib
- Persistent Disease
- Survival advantage
- Progression-free survival
- Epidermal Growth Factor Receptor Inhibitors
- Pembrolizumab
- Platinum
- Acquired resistance
- Therapeutic window
- Mesothelioma
- Systematic review
- Afatinib
Journal Specifications
| Overview | |
| Publisher | Elsevier |
| Language | English |
| Article Processing Charges | USD 2000 |
| Publication Time | 19 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | International Association for the Study of Lung Cancer |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 19 |
| Article Processing Charges | USD 2000 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Blind peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in JTO Clinical and Research Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
- 1 Nov 24
- JTO Clinical and Research Reports
-
Full paper
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors
- 1 Nov 24
- JTO Clinical and Research Reports
-
Full paper
Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
- 1 Nov 24
- JTO Clinical and Research Reports
-
Full paper
Myasthenia Gravis in Patients Treated With Immune Checkpoint Inhibitors
- 1 Nov 24
- JTO Clinical and Research Reports
-
Full paper
Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?
- 1 Nov 24
- JTO Clinical and Research Reports
-
Full paper
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
- 1 Nov 24
- JTO Clinical and Research Reports
Scite analysis
Powered by scite_
594 articles received 2.4k citations see all
- 147 Supporting
- 2,266 Mentioning
- 15 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 6 Errata
- 0 Expression of Concern
FAQs
How many articles did JTO Clinical and Research Reports publish last years ?
In 2023, JTO Clinical and Research Reports published 148 articles.
What is Citescore for JTO Clinical and Research Reports ?
Citescore for JTO Clinical and Research Reports is 1.
Who is the publisher of JTO Clinical and Research Reports ?
Elsevier is the publisher of JTO Clinical and Research Reports.